Disc Medicine, Inc.

NASDAQ: IRON · Healthcare · Biotechnology

PublicHQ Watertown, MA · MiddlesexCIK 0001816736Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH 63DQ —GM —SS 63

v0.1 · 35/100 weight · pillars only

↑ Altman-Z, balance-sheet leverage · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$212.2M

Employees

155

as of 2026-08-08

Market cap

$3.0B

as of 2026-08-08

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$212.2M-$212.2M2025

Operating income-$236.0M-$236.0M2025

Total assets$806.9M$806.9M2025

Liabilities$67.1M$67.1M2025

Equity$739.8M$739.8M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Disc Medicine, Inc.’s financial profile?

Disc Medicine, Inc. earned -$212.2M in FY2025 net income.

Peers · Healthcare

Vicore Pharma Holding AB——MBX Biosciences, Inc. Common Stock——Structure Therapeutics Inc.——Kodiak Sciences Inc.——Trevi Therapeutics, Inc.——Mineralys Therapeutics, Inc.——

Neighbors

Middlesex →

GE Vernova Inc.$38.1B63C Thermo Fisher Scientific Inc.$44.6B86A Analog Devices, Inc.$11.0B87A The TJX Companies, Inc.$60.4B85A Boston Scientific Corporation$20.1B88A Symbotic Inc.$2.2B49D

Key facts

CEOJohn D. Quisel

SectorHealthcare

IndustryBiotechnology

HeadquartersWatertown, MA

ExchangeNASDAQ: IRON

Employees155

IPO date2020-08-12

Latest filings

10-Q2026-07-30 8-K2026-07-30 8-K2026-06-30 8-K2026-06-24 8-K2026-05-05 10-Q2026-05-05 DEF 14A2026-04-28 8-K2026-02-27

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.